abstract BACKGROUND AND OBJECTIVE: Children who experienced intrauterine growth restriction (IUGR) may be at increased risk for adverse developmental outcomes in early childhood. The objective of this study was to carry out a systematic review of neurodevelopmental outcomes from 6 months to 3 years after IUGR.
Intrauterine growth restriction (IUGR) is defined as a significant reduction in fetal growth rate resulting in birth weight in the lowest 10th percentile for gestational age (GA). 1 IUGR is estimated to occur in 5% to 7% of all pregnancies. It is important to distinguish between infants who are small for gestational age (SGA) and those who have experienced true IUGR, which is generally caused by placental insufficiency and is associated with an abnormal umbilical artery pulsatility index on fetal ultrasound. Although some recent studies include abnormal fetal umbilical artery blood flow measured with Doppler ultrasound as a requirement to distinguish SGA from IUGR, many do not, and the terms are often used interchangeably.
IUGR is associated with significant neonatal and pediatric morbidity and mortality. Approximately 5% to 10% of all pregnancies complicated by IUGR result in stillbirth or neonatal death, 2 and suboptimal fetal growth is responsible for at least 25% of all stillbirths. 3 The most common identifiable cause of IUGR is placental insufficiency. Placentally restricted fetuses are chronically hypoxemic and hypoglycemic and have increased blood lactate concentrations. 4 Placental factors include abnormal trophoblast invasion, placental infarcts, placenta previa, circumvallate placenta, chorioangiomata, velamentous umbilical cord insertion, and umbilical-placental vascular anomalies. 4 Gray et al 5 found infarcts and accelerated villous maturation were present in the placentae of 40% of infants with IUGR, as compared with 11% of controls. Most infants with IUGR show an increased postnatal growth velocity with catch-up growth by 2 to 3 years. 6 However, because infants with IUGR have feeding problems and decreased nutritional stores, ∼10% remain susceptible to sustained growth delay. 7 The effects of IUGR continue beyond the neonatal period and may have a profound impact on child development. The poorest outcomes are seen after severe or early-onset IUGR, prematurity, or impaired fetal umbilical arterial flow. Although several follow-up studies indicate neurodevelopmental deficits in children with IUGR, these studies have not been systematically reviewed and the quality of the information has not been adequately assessed. This systematic review evaluates the extent to which IUGR is associated with poor neurodevelopmental outcomes in the first 3 years of life.
METHODS

Search Strategy
The search strategy for the included studies is outlined in Appendix 1. We conducted a comprehensive literature search to identify studies through to March 2014. The search strategy involved searching electronic databases and inspecting bibliographies of retrieved articles. We searched the PubMed, Embase, PsycINFO, Maternity and Infant Care, and CINAHL databases. The following search terms were used: intrauterine, growth restriction, child development, neurodevelopment, early childhood, cognitive, motor, speech, language. An example electronic search strategy can be found in Appendix 1.
Selection of Eligible Studies
The initial database search returned 731 studies. After an initial review of titles and abstracts, 579 articles were excluded. Abstracts of the remaining 152 studies were then reviewed, and a further 35 studies were excluded. Full-text analysis of 117 studies was then conducted, and studies were determined to be ineligible if any of the following applied: study participants did not meet specified criteria for IUGR (birth weight ,10th percentile for GA), follow-up was not at age 6 months to 3 years, study methods were not adequately described, non-IUGR comparison group was not included, or full English text of the article was not available. A total of 101 studies did not meet the inclusion criteria following full-text analysis and 16 were determined to be eligible for inclusion in this review.
Data Extraction and Synthesis
Data were retrieved by using a specifically designed data-extraction form that included the authors, year of publication, and location of study; age at assessment; number and growth status of study and control group infants; exclusion criteria; measure(s) used; and results. Available summary results were then tabulated. A descriptive methodology was chosen, and the results presented as a narrative synthesis of the existing literature related to neurodevelopmental outcomes of children who experienced IUGR.
Quality Assessment
A suitable outline for assessing the quality of evidence relating to prognostics and health outcomes was used. 8 The outline evaluates 6 areas of potential bias: study participation, study attrition, prognostic factor measurement, outcome measurement, confounding factor analysis, and data analysis. We also used the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) retrospective database checklist 9 to evaluate the quality of data sources in the 1 retrospective study included in this review. The adapted qualityassessment outline can be found in Appendix 2.
RESULTS
Included Studies
A total of 16 studies that assessed early neurodevelopment of children who had experienced IUGR were identified and are summarized in Table 1. Among these 16 studies, 15 were prospective cohort studies and 1 was retrospective. Most studies were conducted within developed nations: Spain (5); the United States (3); and 1 each from Austria, Brazil, Canada, England, Israel, Guatemala, Mexico, and the Netherlands. The results of the quality assessment of included studies can be found in Table 2 . In 11 of the 16 included studies, neurodevelopmental outcomes after IUGR are poorer than those after normal intrauterine growth.
From 6 Months to 1 Year
Four studies examined neurodevelopment in children with IUGR between 6 months and 1 year of age. Two of these studies defined IUGR according to low birth weight or fetal abdominal circumference without reference to Doppler parameters. 10, 11 Children with IUGR had higher rates of neuromotor and neurologic abnormalities than controls at 1 year, although most of the abnormalities were mild. 10 IUGR was the best predictor of neurologic impairment at 1 year. Fernandez-Carrocera et al 10 also found that children with IUGR scored significantly lower than controls on the Bayley Scales of Infant Development, version II (Bayley-II), although both groups scored within 1 SD of the mean. 10 Roth et al 11 defined IUGR as a change in fetal abdominal circumference $1.5 SD between the first and last scan, whereas SGA was indicated when fetal abdominal circumference changed ,1.5 SD, and found no significant differences in neurodevelopment between these groups. Even with optimum obstetric management, approximately one-third of the combined SGA and IUGR term fetuses had experienced some neurologic damage. 11 Two of the 4 studies conducted with children between 6 months and 1 year of age who experienced IUGR included abnormal Doppler parameters in their definition of IUGR. 12, 13 In 1 study, preterm infants with asymmetric IUGR had significantly lower neurobehavioral scores on the habituation, motor system, social-interactive, and attention subscales of the Neonatal Behavioral Assessment Scale at 40 weeks when compared with both controls and infants with symmetric IUGR. 12 Asymmetric fetal growth restriction occurs late in pregnancy, and infants show weight reduction but a less marked length reduction. Although generally considered to be a protective "brain-sparing" mechanism, this study suggests otherwise. Padilla et al 13 compared preterm children with and without IUGR using the Hammersmith Infant Neurologic Examination and the Bayley-II at 1 year of age, and found no significant differences between the groups in neurodevelopmental performance. Thus, 2 of the 4 studies assessing neurodevelopment between 6 months and 1 year indicate that these children are at risk for delay.
From 1 to 2 Years
Of the 8 studies assessing neurodevelopment from 1 to 2 years after IUGR, 7 indicate that these children are at increased risk of delay. Three of the 8 studies defined IUGR according to low fetal weight or abdominal circumference without reference to Doppler parameters. Batalle et al 14 found cognitive, linguistic, and motor deficits by using Bayley-II. Streimish et al 15 found that only girls with the most severe growth restriction were at increased risk of neurodevelopmental impairment at 2 years corrected age by using the Bayley-II. Procianoy et al 16 
From 2 to 3 Years
Four studies assessed neurodevelopment after IUGR in children from 2 to 3 years of age. Three of these defined IUGR according to low birth weight for GA without reference to Doppler parameters. Children with IUGR were more likely to be developmentally delayed at age 3 compared with controls, and cephalization index, neonatal risk score, and birth weight were the clinical parameters most significantly correlated with developmental outcome. 22 Villar et al 23 found that children with Guidelines for Assessing Quality in Prognostic Studies. 8 asymmetric IUGR scored lower than controls, whereas children with symmetric IUGR scored lower on mental items at 2 years and had the lowest values on 7 of 8 developmental measures and on the composite score at 3 years. Amin et al 24 found no significant differences in neurodevelopmental outcomes at 3 years between children who had experienced IUGR and matched controls, although persistence of microcephaly was associated with a more adverse neurodevelopmental outcome.
The fourth study, which differentiated between infants with IUGR and infants who were SGA by using abnormal umbilical artery or internal carotid artery Doppler findings, did not find a difference in developmental scores on the Stanford-Binet Intelligence Scale at 3 years. 25 Thus, 2 of the 4 studies available to date that assess early childhood neurodevelopment after IUGR identified these children as at risk for delay, particularly in the incidence of asymmetric growth restriction.
Quality Assessment of Studies
Our assessment of the quality of studies included in this review using the ISPOR Retrospective Database Checklist 9 and guidelines for assessment of prognostic studies 8 is summarized in Appendix 2. One study 20 used an existing data set, but did not fully outline the quality assessment of the original data sources. Nonstandardized outcome measures increased the possibility of measurement bias and made comparability between studies problematic. Adjustment for potentially confounding perinatal, maternal, and socioeconomic factors and neonatal and childhood comorbidities was inadequately outlined in 2 of the 16 studies. 21, 22 Although the number of participants lost to follow-up was generally recorded, attempts to collect information on participants who dropped out of the study, reasons for loss to follow-up, and key characteristics of participants lost to follow-up were adequately described in only 6 of the 16 studies. [11] [12] [13] 19 
